170 related articles for article (PubMed ID: 12827294)
1. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents.
Vernole P; Pepponi R; D'Atri S
Cancer Chemother Pharmacol; 2003 Sep; 52(3):185-92. PubMed ID: 12827294
[TBL] [Abstract][Full Text] [Related]
2. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
[TBL] [Abstract][Full Text] [Related]
3. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
[TBL] [Abstract][Full Text] [Related]
4. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
Aida T; Bodell WJ
Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].
Tronov VA; Kramarenko II; Smirnova TD; Terekhov SM
Tsitologiia; 2006; 48(1):19-27. PubMed ID: 16568831
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and induction of sister chromatid exchanges in human and rodent brain tumor cells treated with alkylating chemotherapeutic agents.
Tokuda K; Bodell WJ
Cancer Res; 1988 Jun; 48(11):3100-5. PubMed ID: 2835151
[TBL] [Abstract][Full Text] [Related]
8. Analysis of microsatellite instability in acquired drug-resistance human tumor cell lines.
Picard SF; Franco N; Sergent C; Chauffert B; Lizard-Nacol S
Oncol Rep; 2002; 9(5):971-6. PubMed ID: 12168057
[TBL] [Abstract][Full Text] [Related]
9. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
[TBL] [Abstract][Full Text] [Related]
10. The role of DNA mismatch repair in drug resistance.
Fink D; Aebi S; Howell SB
Clin Cancer Res; 1998 Jan; 4(1):1-6. PubMed ID: 9516945
[TBL] [Abstract][Full Text] [Related]
11. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML
Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic effects of Me-CCNU on sister chromatid exchange frequency, cellular kinetics and chromosome aberrations.
Shah VC; Vyas RC; Adhvaryu SG
Neoplasma; 1986; 33(1):33-7. PubMed ID: 3754313
[TBL] [Abstract][Full Text] [Related]
13. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
Kaina B; Christmann M; Naumann S; Roos WP
DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair.
Kondo A; Safaei R; Mishima M; Niedner H; Lin X; Howell SB
Cancer Res; 2001 Oct; 61(20):7603-7. PubMed ID: 11606400
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
Yamane K; Schupp JE; Kinsella TJ
Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687
[TBL] [Abstract][Full Text] [Related]
16. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair.
Lin X; Trang J; Okuda T; Howell SB
Clin Cancer Res; 2006 Jan; 12(2):563-8. PubMed ID: 16428501
[TBL] [Abstract][Full Text] [Related]
17. N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells.
Aquilina G; Ceccotti S; Martinelli S; Hampson R; Bignami M
Cancer Res; 1998 Jan; 58(1):135-41. PubMed ID: 9426069
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the induction of chromosome damage and cytotoxicity for amsacrine and congeners.
Ferguson LR; Baguley BC
Cancer Treat Rep; 1984 Apr; 68(4):625-30. PubMed ID: 6546899
[TBL] [Abstract][Full Text] [Related]
19. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
[TBL] [Abstract][Full Text] [Related]
20. Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1.
Vernole P; Muzi A; Volpi A; Terrinoni A; Dorio AS; Tentori L; Shah GM; Graziani G
Mutat Res; 2011 Jul; 712(1-2):40-8. PubMed ID: 21570414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
